Hisamitsu Pharmaceutical Co., Inc.
HTSUY · OTC
8/31/2025 | 5/31/2025 | 2/28/2025 | 11/30/2024 | |
|---|---|---|---|---|
| Market Cap | – | $2 | $2 | $2 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | – | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 15.8% | -18.3% | 20.9% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 61.6% | 61.4% | 55.4% | 61.4% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 20% | 15.8% | 24.8% | 21.9% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 11.1% | 7.4% | 18.1% | 12.7% |
| EPS Diluted | 0.11 | 0.06 | 0.18 | 0.1 |
| % Growth | 83% | -66.6% | 80% | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |